Ionis Pharmaceuticals IONS
NASDAQ IONS
$58.09 -0.04 (-0.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Ionis Pharmaceuticals (IONS) Gross Margin Growth (5y) (2023 - 2026)

Analysis

Ionis Pharmaceuticals (IONS) Gross Margin Growth (5y) (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ionis Pharmaceuticals 9.60 Bn 7.55 Bn 265.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 133.00
Mar 31, 2026 110.00
Dec 31, 2025 -278.00
Sep 30, 2025 44.00
Jun 30, 2025 115.00
Mar 31, 2025 80.00
Dec 31, 2024 -149.00
Sep 30, 2024 -22.00
Jun 30, 2024 -102.00
Mar 31, 2024 -145.00
Dec 31, 2023 0.00
Sep 30, 2023 -152.00
Jun 30, 2023 -135.00
Mar 31, 2023 -103.00